Tuberous Sclerosis

HomePatientsLung Disease Week at the ATS2015Tuberous Sclerosis ▶ Information for Experts
Information for Experts

Tuberous Sclerosis

 

ClinicianATS Educational Products

 

2014

B83 BREATHMAKING PROGRESS IN RARE INTERSTITIAL LUNG DISEASES
PG14

INTERSTITIAL LUNG DISEASE: THE LATEST ON DIAGNOSIS AND MANAGEMENT

 

2013

C2 CONTROVERSIES IN CONNECTIVE TISSUE DISORDERS-INTERSTITIAL LUNG DISEASE:  A PRO-CON DEBATE
PCC2 INTERSTITIAL LUNG DISEASE AND DIFFUSE ALVEOLAR HEMORRHAGE SYNDROMES
PG10 AN UPDATE ON THE DIAGNOSIS AND MANAGEMENT OF INTERSTITIAL LUNG DISEASE

 

For more Best of ATS Conferences materials visit the following link https://store.thoracic.org or please contact Barbara Horner at bhorner@thoracic.org

 


 

ClinicianATS Journal articles on Tuberous Sclerosis

 

AJRCMB

Statins in Lymphangioleiomyomatosis. Simvastatin and Atorvastatin Induce Differential Effects on tuberous sclerosis complex 2–Null Cell Growth and Signaling
Vol. 49, No. 5 (2013), pp. 704-709.
Read Abstract

Rapamycin-Insensitive Up-Regulation of MMP2 and Other Genes in Tuberous Sclerosis Complex 2–Deficient Lymphangioleiomyomatosis-Like Cells
Vol. 42, No. 2 (2010), pp. 227-234.
Read Abstract

 


 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below: